FTC wants 'pharma bro' Shkreli held in contempt; will insulin ever be affordable?

The FTC has asked a federal judge to hold "pharma bro" Martin Shkreli in contempt over a lifelong ban on working in the drug industry.‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

January 20, 2023 Check out STAT+

Sponsored By

Mark Wilson/Getty Images STAT+ | FTC wants 'pharma bro' Martin Shkreli held in contempt for violating lifelong ban on working in pharma The FTC claims Shkreli has failed to comply with requests to provide documents and sit for an interview as part of an investigation. By Ed Silverman Opinion: Even with lawsuits and copay caps, will insulin ever be affordable? People who rely on outrageously priced insulin need more than state-by-state lawsuits and a cap on co-pays to afford this essential medicine. By Danielle Ofri Buprenorphine deaths did not increase despite wider access during pandemic, study shows Despite the medication's wider availability, deaths involving buprenorphine still constitute a small fraction of overall drug mortality. By Lev Facher Kristoffer Tripplaar/AP STAT+ | FDA rejects Lilly's bid for accelerated approval for its Alzheimer's drug The drugmaker said the readout from a Phase 3 study is on track, and if positive, will form the basis of an application for full approval. By Adam Feuerstein Is mesothelin a key to tackling solid tumors? Some biotech companies are betting that it is Mesothelin, a protein found on cancer cells and also in healthy tissue, may be a key to tackling solid tumors, some biotechs believe. By Angus Chen Opinion: The WHO's new pandemic treaty is good for the world — and the U.S. A proposed global treaty on pandemic preparedness and response would strengthen global health, which has direct effects on Americans' health. By Sergio Imparato and Sarosh Nagar

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

REPORTS NEWSLETTERS EVENTS STAT+

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •     Contact Us     •     Advertise with Us     •     View in Browser